Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Editorial

  • Editorial
    Setting the Standard for Translational Cancer Research
    Kenneth C. Anderson
    Clin Cancer Res January 1 2009 15 (1) 1-1; DOI:10.1158/1078-0432.CCR-15-1-ED

Molecular Pathways

  • Molecular Pathways
    Peroxisome Proliferator-Activated Receptor γ Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
    Frank Ondrey
    Clin Cancer Res January 1 2009 15 (1) 2-8; DOI:10.1158/1078-0432.CCR-08-0326

  • Molecular Pathways
    Heat Shock Protein 90 as a Drug Target: Some Like It Hot
    Udai Banerji
    Clin Cancer Res January 1 2009 15 (1) 9-14; DOI:10.1158/1078-0432.CCR-08-0132

Review

  • Review
    Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer
    Vincent O. Dezentjé, Henk-Jan Guchelaar, Johan W.R. Nortier, Cornelis J.H. van de Velde and Hans Gelderblom
    Clin Cancer Res January 1 2009 15 (1) 15-21; DOI:10.1158/1078-0432.CCR-08-2006

Human Cancer Biology

  • Human Cancer Biology
    S100A2 Induces Metastasis in Non–Small Cell Lung Cancer
    Etmar Bulk, Bülent Sargin, Utz Krug, Antje Hascher, Yu Jun, Markus Knop, Claus Kerkhoff, Volker Gerke, Ruediger Liersch, Rolf M. Mesters, Marc Hotfilder, Alessandro Marra, Steffen Koschmieder, Martin Dugas, Wolfgang E. Berdel, Hubert Serve and Carsten Müller-Tidow
    Clin Cancer Res January 1 2009 15 (1) 22-29; DOI:10.1158/1078-0432.CCR-08-0953

  • Human Cancer Biology
    Array Comparative Genomic Hybridization Analysis of PTCL-U Reveals a Distinct Subgroup with Genetic Alterations Similar to Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
    Masao Nakagawa, Aya Nakagawa-Oshiro, Sivasundaram Karnan, Hiroyuki Tagawa, Atae Utsunomiya, Shigeo Nakamura, Ichiro Takeuchi, Koichi Ohshima and Masao Seto
    Clin Cancer Res January 1 2009 15 (1) 30-38; DOI:10.1158/1078-0432.CCR-08-1808

  • Human Cancer Biology
    In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
    Robert Snoek, Helen Cheng, Katia Margiotti, Latif A. Wafa, Charmaine A. Wong, Erica Chan Wong, Ladan Fazli, Colleen C. Nelson, Martin E. Gleave and Paul S. Rennie
    Clin Cancer Res January 1 2009 15 (1) 39-47; DOI:10.1158/1078-0432.CCR-08-1726

  • Human Cancer Biology
    Intracellular Clusterin Inhibits Mitochondrial Apoptosis by Suppressing p53-Activating Stress Signals and Stabilizing the Cytosolic Ku70-Bax Protein Complex
    Ioannis P. Trougakos, Magda Lourda, Marianna H. Antonelou, Dimitris Kletsas, Vassilis G. Gorgoulis, Issidora S. Papassideri, Yonglong Zou, Lukas H. Margaritis, David A. Boothman and Efstathios S. Gonos
    Clin Cancer Res January 1 2009 15 (1) 48-59; DOI:10.1158/1078-0432.CCR-08-1805

  • Human Cancer Biology
    Proapoptotic Function of Integrin β3 in Human Hepatocellular Carcinoma Cells
    Yanhua Wu, Jie Zuo, Guoqing Ji, Hexige Saiyin, Xing Liu, Feiyu Yin, Ning Cao, Yunfei Wen, Jian Jian Li and Long Yu
    Clin Cancer Res January 1 2009 15 (1) 60-69; DOI:10.1158/1078-0432.CCR-08-1028

  • Human Cancer Biology
    Niche-Dependent Tumorigenic Capacity of Malignant Ovarian Ascites-Derived Cancer Cell Subpopulations
    Ehood Katz, Karl Skorecki and Maty Tzukerman
    Clin Cancer Res January 1 2009 15 (1) 70-80; DOI:10.1158/1078-0432.CCR-08-1233

  • Human Cancer Biology
    Cytoplasmic Sequestration of p27 via AKT Phosphorylation in Renal Cell Carcinoma
    Jinhee Kim, Eric Jonasch, Angela Alexander, John D. Short, Shengli Cai, Sijin Wen, Dimitra Tsavachidou, Pheroze Tamboli, Bogdan A. Czerniak, Kim Anh Do, Kevin J. Wu, Laura A. Marlow, Christopher G. Wood, John A. Copland and Cheryl Lyn Walker
    Clin Cancer Res January 1 2009 15 (1) 81-90; DOI:10.1158/1078-0432.CCR-08-0170

  • Human Cancer Biology
    Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
    Ina Oehme, Hedwig E. Deubzer, Dennis Wegener, Diana Pickert, Jan-Peter Linke, Barbara Hero, Annette Kopp-Schneider, Frank Westermann, Scott M. Ulrich, Andreas von Deimling, Matthias Fischer and Olaf Witt
    Clin Cancer Res January 1 2009 15 (1) 91-99; DOI:10.1158/1078-0432.CCR-08-0684

Cancer Therapy: Preclinical

  • Cancer Therapy: Preclinical
    Intracellular MUC1 Peptides Inhibit Cancer Progression
    Benjamin G. Bitler, Ina Menzl, Carmen L. Huerta, Barbara Sands, Wendy Knowlton, Andrew Chang and Joyce A. Schroeder
    Clin Cancer Res January 1 2009 15 (1) 100-109; DOI:10.1158/1078-0432.CCR-08-1745

  • Cancer Therapy: Preclinical
    Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors
    Angela Coxon, Tammy Bush, Douglas Saffran, Stephen Kaufman, Brian Belmontes, Karen Rex, Paul Hughes, Sean Caenepeel, James B. Rottman, Andrew Tasker, Vinod Patel, Richard Kendall, Robert Radinsky and Anthony Polverino
    Clin Cancer Res January 1 2009 15 (1) 110-118; DOI:10.1158/1078-0432.CCR-08-1155

  • Cancer Therapy: Preclinical
    Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene
    Tao Deng, Jeff C. Liu, Kathleen I. Pritchard, Andrea Eisen and Eldad Zacksenhaus
    Clin Cancer Res January 1 2009 15 (1) 119-130; DOI:10.1158/1078-0432.CCR-08-1708

  • Cancer Therapy: Preclinical
    Intratumoral Delivery of β-Lapachone via Polymer Implants for Prostate Cancer Therapy
    Ying Dong, Shook-Fong Chin, Elvin Blanco, Erik A. Bey, Wareef Kabbani, Xian-Jin Xie, William G. Bornmann, David A. Boothman and Jinming Gao
    Clin Cancer Res January 1 2009 15 (1) 131-139; DOI:10.1158/1078-0432.CCR-08-1691

  • Cancer Therapy: Preclinical
    Induction of Apoptosis in Human Leukemia Cells by Grape Seed Extract Occurs via Activation of c-Jun NH2-Terminal Kinase
    Ning Gao, Amit Budhraja, Senping Cheng, Hua Yao, Zhuo Zhang and Xianglin Shi
    Clin Cancer Res January 1 2009 15 (1) 140-149; DOI:10.1158/1078-0432.CCR-08-1447

  • Cancer Therapy: Preclinical
    BH3 Mimetic Obatoclax Enhances TRAIL-Mediated Apoptosis in Human Pancreatic Cancer Cells
    Shengbing Huang, Kenji Okumura and Frank A. Sinicrope
    Clin Cancer Res January 1 2009 15 (1) 150-159; DOI:10.1158/1078-0432.CCR-08-1575

  • Cancer Therapy: Preclinical
    Reoxygenation of Hypoxic Glioblastoma Multiforme Cells Potentiates the Killing Effect of an Interleukin-13-Based Cytotoxin
    Tie Fu Liu, Jiaozhong Cai, Denise M. Gibo and Waldemar Debinski
    Clin Cancer Res January 1 2009 15 (1) 160-168; DOI:10.1158/1078-0432.CCR-08-2151

  • Cancer Therapy: Preclinical
    Characterization of Genetically Modified T-Cell Receptors that Recognize the CEA:691-699 Peptide in the Context of HLA-A2.1 on Human Colorectal Cancer Cells
    Maria R. Parkhurst, Jayne Joo, John P. Riley, Zhiya Yu, Yong Li, Paul F. Robbins and Steven A. Rosenberg
    Clin Cancer Res January 1 2009 15 (1) 169-180; DOI:10.1158/1078-0432.CCR-08-1638

  • Cancer Therapy: Preclinical
    Polymeric Tubulysin-Peptide Nanoparticles with Potent Antitumor Activity
    Thomas Schluep, Paula Gunawan, Ling Ma, Gregory S. Jensen, Julienne Duringer, Steven Hinton, Wolfgang Richter and Jungyeong Hwang
    Clin Cancer Res January 1 2009 15 (1) 181-189; DOI:10.1158/1078-0432.CCR-08-1848

  • Cancer Therapy: Preclinical
    RRR-α-Vitamin E Succinate Potentiates the Antitumor Effect of Calcitriol in Prostate Cancer without Overt Side Effects
    Yi Yin, Jing Ni, Ming Chen, Yinglu Guo and Shuyuan Yeh
    Clin Cancer Res January 1 2009 15 (1) 190-200; DOI:10.1158/1078-0432.CCR-08-0910

  • Cancer Therapy: Preclinical
    Tissue Specific Cytotoxicity of Colon Cancer Cells Mediated by Nanoparticle-delivered Suicide Gene In vitro and In vivo
    Guiying Zhang, Ting Liu, Yong-Heng Chen, Yuxiang Chen, Meihua Xu, Jie Peng, Shuyi Yu, Jianwei Yuan and Xiuwu Zhang
    Clin Cancer Res January 1 2009 15 (1) 201-207; DOI:10.1158/1078-0432.CCR-08-1094

  • Cancer Therapy: Preclinical
    rNAPc2 Inhibits Colorectal Cancer in Mice through Tissue Factor
    Jingsong Zhao, Gerard Aguilar, Servando Palencia, Elizabeth Newton and Arie Abo
    Clin Cancer Res January 1 2009 15 (1) 208-216; DOI:10.1158/1078-0432.CCR-08-0407

  • Cancer Therapy: Preclinical
    Mechanism and Management of AKT Inhibitor-Induced Hyperglycemia
    Ming-Chih Crouthamel, Jason A. Kahana, Susan Korenchuk, Shu-Yun Zhang, Gobalakrishnan Sundaresan, Derek J. Eberwein, Kathleen K. Brown and Rakesh Kumar
    Clin Cancer Res January 1 2009 15 (1) 217-225; DOI:10.1158/1078-0432.CCR-08-1253

  • Cancer Therapy: Preclinical
    BMS-536924 Reverses IGF-IR-Induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells
    Beate C. Litzenburger, Hyun-Jung Kim, Isere Kuiatse, Joan M. Carboni, Ricardo M. Attar, Marco M. Gottardis, Craig R. Fairchild and Adrian V. Lee
    Clin Cancer Res January 1 2009 15 (1) 226-237; DOI:10.1158/1078-0432.CCR-08-0801

Imaging, Diagnosis, Prognosis

  • Imaging, Diagnosis, Prognosis
    Advancing Bioluminescence Imaging Technology for the Evaluation of Anticancer Agents in the MDA-MB-435-HAL-Luc Mammary Fat Pad and Subrenal Capsule Tumor Models
    Cathy Zhang, Zhengming Yan, Maria E. Arango, Cory L. Painter and Kenna Anderes
    Clin Cancer Res January 1 2009 15 (1) 238-246; DOI:10.1158/1078-0432.CCR-08-0897

  • Imaging, Diagnosis, Prognosis
    Imaging Intratumoral Convection: Pressure-Dependent Enhancement in Chemotherapeutic Delivery to Solid Tumors
    Terence P.F. Gade, Ian M. Buchanan, Matthew W. Motley, Yousef Mazaheri, William M. Spees and Jason A. Koutcher
    Clin Cancer Res January 1 2009 15 (1) 247-255; DOI:10.1158/1078-0432.CCR-08-0611

  • Imaging, Diagnosis, Prognosis
    Involvement of Epithelial Cell Transforming Sequence-2 Oncoantigen in Lung and Esophageal Cancer Progression
    Daizaburo Hirata, Takumi Yamabuki, Daiki Miki, Tomoo Ito, Eiju Tsuchiya, Masahiro Fujita, Masao Hosokawa, Kazuaki Chayama, Yusuke Nakamura and Yataro Daigo
    Clin Cancer Res January 1 2009 15 (1) 256-266; DOI:10.1158/1078-0432.CCR-08-1672

  • Imaging, Diagnosis, Prognosis
    Validation of a Standardized Method for Enumerating Circulating Endothelial Cells and Progenitors: Flow Cytometry and Molecular and Ultrastructural Analyses
    Patrizia Mancuso, Pierluigi Antoniotti, Jessica Quarna, Angelica Calleri, Cristina Rabascio, Carlo Tacchetti, Paola Braidotti, Hua-Kang Wu, Amado J. Zurita, Luca Saronni, John B. Cheng, David R. Shalinsky, John V. Heymach and Francesco Bertolini
    Clin Cancer Res January 1 2009 15 (1) 267-273; DOI:10.1158/1078-0432.CCR-08-0432

  • Imaging, Diagnosis, Prognosis
    SCG3 Transcript in Peripheral Blood Is a Prognostic Biomarker for REST-Deficient Small Cell Lung Cancer
    Adrian C. Moss, Gregory M. Jacobson, Lauren E. Walker, Neil W. Blake, Ernie Marshall and Judy M. Coulson
    Clin Cancer Res January 1 2009 15 (1) 274-283; DOI:10.1158/1078-0432.CCR-08-1163

  • Imaging, Diagnosis, Prognosis
    An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non–Small-Cell Lung Cancer
    Paul Roepman, Jacek Jassem, Egbert F. Smit, Thomas Muley, Jacek Niklinski, Tony van de Velde, Anke T. Witteveen, Witold Rzyman, Arno Floore, Sjaak Burgers, Giuseppe Giaccone, Michael Meister, Hendrik Dienemann, Marcin Skrzypski, Miroslaw Kozlowski, Wolter J. Mooi and Nico van Zandwijk
    Clin Cancer Res January 1 2009 15 (1) 284-290; DOI:10.1158/1078-0432.CCR-08-1258

  • Imaging, Diagnosis, Prognosis
    Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Carcinoma Patients Receiving Adjuvant Chemotherapy and Is Not Associated with EBV Infection
    Eun Soo Park, In Gu Do, Cheol Keun Park, Won Ki Kang, Jae Hyung Noh, Tae Sung Sohn, Sung Kim, Min-Ji Kim and Kyoung-Mee Kim
    Clin Cancer Res January 1 2009 15 (1) 291-298; DOI:10.1158/1078-0432.CCR-08-0848

Cancer Therapy: Clinical

  • Cancer Therapy: Clinical
    HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine
    Gilles Bioley, Philippe Guillaume, Immanuel Luescher, Alice Yeh, Bo Dupont, Nina Bhardwaj, Gregory Mears, Lloyd J. Old, Danila Valmori and Maha Ayyoub
    Clin Cancer Res January 1 2009 15 (1) 299-306; DOI:10.1158/1078-0432.CCR-08-1747

  • Cancer Therapy: Clinical
    Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study
    Javier Cortes, Serena Di Cosimo, Miguel A. Climent, Hernán Cortés-Funes, Ana Lluch, Pere Gascón, José I. Mayordomo, Miguel Gil, Manuel Benavides, Lluís Cirera, Belén Ojeda, César A. Rodríguez, José M. Trigo, Josep Vazquez, Pilar Regueiro, Juan F. Dorado and José Baselga
    Clin Cancer Res January 1 2009 15 (1) 307-314; DOI:10.1158/1078-0432.CCR-08-1113

  • Cancer Therapy: Clinical
    DNA Methylation Markers Predict Outcome in Node-Positive, Estrogen Receptor-Positive Breast Cancer with Adjuvant Anthracycline-Based Chemotherapy
    Oliver Hartmann, Frédérique Spyratos, Nadia Harbeck, Dimo Dietrich, Anne Fassbender, Manfred Schmitt, Serenella Eppenberger-Castori, Vincent Vuaroqueaux, Florence Lerebours, Katrin Welzel, Sabine Maier, Achim Plum, Stephan Niemann, John A. Foekens, Ralf Lesche and John W.M. Martens
    Clin Cancer Res January 1 2009 15 (1) 315-323; DOI:10.1158/1078-0432.CCR-08-0166

  • Cancer Therapy: Clinical
    Overexpression of the KIT/SCF in Uveal Melanoma Does Not Translate into Clinical Efficacy of Imatinib Mesylate
    Uta B. Hofmann, Claudia S. Kauczok-Vetter, Roland Houben and Jürgen C. Becker
    Clin Cancer Res January 1 2009 15 (1) 324-329; DOI:10.1158/1078-0432.CCR-08-2243

  • Cancer Therapy: Clinical
    Phase II Study of Protracted Daily Temozolomide for Low-Grade Gliomas in Adults
    Santosh Kesari, David Schiff, Jan Drappatz, Debra LaFrankie, Lisa Doherty, Eric A. Macklin, Alona Muzikansky, Sandro Santagata, Keith L. Ligon, Andrew D. Norden, Abigail Ciampa, Joanna Bradshaw, Brenda Levy, Gospova Radakovic, Naren Ramakrishna, Peter M. Black and Patrick Y. Wen
    Clin Cancer Res January 1 2009 15 (1) 330-337; DOI:10.1158/1078-0432.CCR-08-0888

  • Cancer Therapy: Clinical
    O6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
    Matthew H. Kulke, Jason L. Hornick, Christine Frauenhoffer, Susanne Hooshmand, David P. Ryan, Peter C. Enzinger, Jeffrey A. Meyerhardt, Jeffrey W. Clark, Keith Stuart, Charles S. Fuchs and Mark S. Redston
    Clin Cancer Res January 1 2009 15 (1) 338-345; DOI:10.1158/1078-0432.CCR-08-1476

  • Cancer Therapy: Clinical
    Population Pharmacokinetic/Pharmacodynamic Analyses of Pemetrexed and Neutropenia: Effect of Vitamin Supplementation and Differences between Japanese and Western Patients
    Jane E. Latz, Karen Lee Schneck, Kazuhiko Nakagawa, Mary Alice Miller and Chris H. Takimoto
    Clin Cancer Res January 1 2009 15 (1) 346-354; DOI:10.1158/1078-0432.CCR-08-0791

  • Cancer Therapy: Clinical
    Lenalidomide and Rituximab in Waldenstrom's Macroglobulinemia
    Steven P. Treon, Jacob D. Soumerai, Andrew R. Branagan, Zachary R. Hunter, Christopher J. Patterson, Leukothea Ioakimidis, Luis Chu, Paul Musto, Ari D. Baron, Johannes C. Nunnink, Joseph J. Kash, Terenig O. Terjanian, Paul M. Hyman, Elena L. Nawfel, David J. Sharon, Nikhil C. Munshi and Kenneth C. Anderson
    Clin Cancer Res January 1 2009 15 (1) 355-360; DOI:10.1158/1078-0432.CCR-08-0862

  • Cancer Therapy: Clinical
    A Phase I Trial of a Human Papillomavirus DNA Vaccine for HPV16+ Cervical Intraepithelial Neoplasia 2/3
    Cornelia L. Trimble, Shiwen Peng, Ferdynand Kos, Patti Gravitt, Raphael Viscidi, Elizabeth Sugar, Drew Pardoll and T.C. Wu
    Clin Cancer Res January 1 2009 15 (1) 361-367; DOI:10.1158/1078-0432.CCR-08-1725

  • Cancer Therapy: Clinical
    Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia
    Srdan Verstovsek, Ayalew Tefferi, Hagop Kantarjian, Taghi Manshouri, Raja Luthra, Animesh Pardanani, Alfonso Quintás-Cardama, Farhad Ravandi, Pat Ault, Carlos Bueso-Ramos and Jorge E. Cortes
    Clin Cancer Res January 1 2009 15 (1) 368-373; DOI:10.1158/1078-0432.CCR-08-1302

  • Cancer Therapy: Clinical
    Phase I and Pharmacokinetic Study of Gimatecan Given Orally Once a Week for 3 of 4 Weeks in Patients with Advanced Solid Tumors
    Andrew X. Zhu, Neal Ready, Jeffrey W. Clark, Howard Safran, Antonino Amato, Nadia Salem, Silvia Pace, Xiaoying He, Nela Zvereva, Thomas J. Lynch, David P. Ryan and Jeffrey G. Supko
    Clin Cancer Res January 1 2009 15 (1) 374-381; DOI:10.1158/1078-0432.CCR-08-1024

  • Cancer Therapy: Clinical
    Phase I and Pharmacokinetic Study of Pemetrexed plus Cisplatin in Chemonaive Patients with Locally Advanced or Metastatic Malignant Pleural Mesothelioma or Non–Small Cell Lung Cancer
    Nicolas J. Dickgreber, Thomas H. Fink, Jane E. Latz, Anwar M. Hossain, Luna C. Musib and Michael Thomas
    Clin Cancer Res January 1 2009 15 (1) 382-389; DOI:10.1158/1078-0432.CCR-08-0128

  • Cancer Therapy: Clinical
    Intratumoral Immune Cell Infiltrates, FoxP3, and Indoleamine 2,3-Dioxygenase in Patients with Melanoma Undergoing CTLA4 Blockade
    Antoni Ribas, Begoña Comin-Anduix, James S. Economou, Timothy R. Donahue, Pilar de la Rocha, Lilah F. Morris, Jason Jalil, Vivian B. Dissette, Itsushi Peter Shintaku, John A. Glaspy, Jesus Gomez-Navarro and Alistair J. Cochran
    Clin Cancer Res January 1 2009 15 (1) 390-399; DOI:10.1158/1078-0432.CCR-08-0783

Cancer Prevention and Susceptibility

  • Cancer Prevention and Susceptibility
    Interactions of IL-12A and IL-12B Polymorphisms on the Risk of Cervical Cancer in Chinese Women
    Xiaojun Chen, Suping Han, Sumin Wang, Xiaoyi Zhou, Mingfeng Zhang, Jing Dong, Xiaoyan Shi, Nianfeng Qian, Xinru Wang, Qingyi Wei, Hongbing Shen and Zhibin Hu
    Clin Cancer Res January 1 2009 15 (1) 400-405; DOI:10.1158/1078-0432.CCR-08-1829

  • Cancer Prevention and Susceptibility
    Role of the N-Acetyltransferase 2 Detoxification System in Thyroid Cancer Susceptibility
    Ana C.T. Guilhen, Natassia E. Bufalo, Elaine C. Morari, Janaina L. Leite, Ligia V.M. Assumpcao, Alfio J.A. Tincani and Laura S. Ward
    Clin Cancer Res January 1 2009 15 (1) 406-412; DOI:10.1158/1078-0432.CCR-08-1835

Letters to the Editor

  • Letters to the Editor
    Prediction of Cancer Relapse after Prostatectomy: Use the Postoperative Nomogram
    Gaelle Fromont
    Clin Cancer Res January 1 2009 15 (1) 413-413; DOI:10.1158/1078-0432.CCR-08-1869

  • Letters to the Editor
    Reply to the Letter to the Editor from Fromont
    Shahrokh F. Shariat and Pierre I. Karakiewicz
    Clin Cancer Res January 1 2009 15 (1) 413-413; DOI:10.1158/1078-0432.CCR-08-2112

  • Letters to the Editor
    Biomarkers and Response to Therapy in Breast Cancer
    Adrian M. Jubb
    Clin Cancer Res January 1 2009 15 (1) 414-414; DOI:10.1158/1078-0432.CCR-08-2404

  • Letters to the Editor
    Reply to the Letter to the Editor from Jubb
    Sherry X. Yang and Sandra M. Swain
    Clin Cancer Res January 1 2009 15 (1) 414-414; DOI:10.1158/1078-0432.CCR-08-2602

Corrections

  • Corrections
    Correction: Article on In vivo and Microarray Analysis of Rexinoid-Responsive Anaplastic Thyroid Carcinoma
    Clin Cancer Res January 1 2009 15 (1) 416-416; DOI:10.1158/1078-0432.CCR-15-1-COR1

  • Corrections
    Correction: Article on Vandetanib Inhibition of Growth of Adenoid Cystic Carcinoma in an Orthotopic Nude Mouse Model
    Clin Cancer Res January 1 2009 15 (1) 416-416; DOI:10.1158/1078-0432.CCR-15-1-COR2

  • Corrections
    Correction: Article on a Phase II Trial of Vorinostat in Metastatic Breast Cancer
    Clin Cancer Res January 1 2009 15 (1) 416-416; DOI:10.1158/1078-0432.CCR-15-1-COR3

Back to top
PreviousNext
Clinical Cancer Research: 15 (1)
January 2009
Volume 15, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

Issue Highlights

  • Heat Shock Protein 90 as a Drug Target: Some Like It Hot
  • Proapoptotic Function of Integrin β3 in Human Hepatocellular Carcinoma Cells
  • Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II Study
  • Niche-Dependent Tumorigenic Capacity of Malignant Ovarian Ascites-Derived Cancer Cell Subpopulations

Jump to

  • Editorial
  • Molecular Pathways
  • Review
  • Human Cancer Biology
  • Cancer Therapy: Preclinical
  • Imaging, Diagnosis, Prognosis
  • Cancer Therapy: Clinical
  • Cancer Prevention and Susceptibility
  • Letters to the Editor
  • Corrections
Advertisement
  • Most Cited
  • Most Read
Loading
  • FLASH-RT Spares Lung Progenitor Cells
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • scRNA-seq Analysis of Gastric Cancer TME
  • PDAC and GATA6 Expression
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement